SLAS 2021 Resources

 ● SLAS 2021 Resources ● 

Featured Presentation at SLAS 2021
NanoBRET™ Technology to Quantify Live Cell Target Engagement at RAS and Its Downstream Effectors
As a driver of tumorigenesis in numerous cell types, the RAS-MAPK pathway has been the subject of concerted drug discovery efforts for decades. Here we will present the use of NanoBRET™ technology to quantify live-cell target engagement to all described drug binding sites within the RAS-RAF-MEK-ERK pathway.
 

Presented by Matt Robers 

 Sr Research Scientist, Promega Corporation 

Monday, January 25, 2021

7:00—7:30pm EST



 ►Watch Video 

​—​—​—​—​—​—​—​—​—​—​—​—​—​—​—​—​—​—​—​—​—​—​—​—​—​—​—​—​—​—​—​—​—​—​—​—​—​—​—​—​—​—​—​—​—​—​—​—​—

Scientific Posters

Tecan the Pressure Off: A Fully Automated High-Throughput Mammalian Purification Platform Utilising Magnetic Bead Technology
Presenter by Jade Scott, GlaxoSmithKline-Stevenage, UK



 ►Download PDF